Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,782 | -20,791 | -11,267 | -38,980 | -27,359 |
| Depreciation Amortization | 605 | 410 | 205 | 760 | 556 |
| Accounts receivable | -610 | -522 | N/A | N/A | N/A |
| Other Working Capital | -4,729 | 1,674 | -132 | 4,211 | -1,009 |
| Other Operating Activity | 8,157 | 4,078 | 2,719 | 7,599 | 5,299 |
| Operating Cash Flow | $-24,359 | $-15,151 | $-8,475 | $-26,411 | $-22,513 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,501 | 14,500 | 9,500 | -18,500 | N/A |
| PPE Investments | 91 | 108 | -19 | -1,854 | -1,734 |
| Purchase Of Investment | 0 | N/A | N/A | N/A | -23,307 |
| Investing Cash Flow | $18,592 | $14,608 | $9,481 | $-20,354 | $-25,041 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,296 | 4,004 | 257 | 4,182 | 12 |
| Financing Cash Flow | $16,296 | $4,004 | $257 | $4,182 | $12 |
| Beginning Cash Position | 21,000 | 21,000 | 20,850 | 63,584 | 63,584 |
| End Cash Position | 31,529 | 24,461 | 22,113 | 21,000 | 16,042 |
| Net Cash Flow | $10,529 | $3,461 | $1,263 | $-42,583 | $-47,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,359 | -15,151 | -8,475 | -26,411 | -22,513 |
| Capital Expenditure | -36 | -19 | -19 | -1,854 | -1,734 |
| Free Cash Flow | -24,395 | -15,170 | -8,494 | -28,265 | -24,247 |